Traws Pharma’s Bird Flu Drug Candidate, Tivoxavir Marboxil, Presented at ICAR – BioSpace Poster underscores Tivoxavir Marboxil’s potential for the treatment of bird flu, supported by 100% survival in a rodent challenge model, … Read More at Source. Author: Pumilo Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook More Click to share on LinkedIn (Opens in new window) LinkedIn Click to share on Reddit (Opens in new window) Reddit Click to share on Tumblr (Opens in new window) Tumblr Click to share on Pinterest (Opens in new window) Pinterest Click to share on Pocket (Opens in new window) Pocket Click to share on Telegram (Opens in new window) Telegram Click to share on WhatsApp (Opens in new window) WhatsApp Like this:Like Loading... Related Tags: BirdNews March 24, 2025 by Pumilo Bird News 0
